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Objectives
At the conclusion of this session, the participant 
will be able to:
 Describe current CDC guidance for clinicians caring for 
women and men of reproductive age with possible Zika 
exposure
 Explain the purpose and scope of the US Zika Pregnancy 
Registry and clinicians' role in ensuring its success
 Interpret pediatric testing guidance in newborns and 
infants with possible Zika virus infection
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9Topics to be covered
 Brief overview 
 Updated Interim Guidance for Prevention of Sexual Transmission of Zika Virus 
 Updated Interim Guidance for Health Care Providers Caring for Women of 
Reproductive Age with Possible Zika Virus Exposure 
 Preventing Transmission of Zika Virus in Labor and Delivery Settings Through 
Implementation of Standard Precautions 
 Interpretation of Pediatric Testing Guidance
 U.S. Zika Pregnancy Registry
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What is Zika virus disease?
 Disease spread primarily through the bite of an 
Aedes mosquito infected with Zika virus
– Aggressive daytime biters, live indoors and 
outdoors
– Can also bite at night
 Symptoms are mild and last for several days to 
a week:
– Fever, maculopapular rash, arthralgia, 
conjunctivitis 
– Myalgia, headache




Transmission of Zika virus
 Other modes of transmission
– Intrauterine and perinatal transmission
– Sexual transmission
– Laboratory exposure
 Theoretical modes of transmission
– Blood transfusion
– Organ or tissue transplantation
– Breast milk
– Fertility treatment
 33 countries and territories in the Americas and 41 countries worldwide 
reporting active Zika virus transmission (as of 4/11/16)
Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika virus. NEJM DOI: 10.1056/NEJMra1602113
CDC: All Countries and Territories with Active Zika Virus Transmission Link to Areas with Active Zika (accessed 4/11/16)
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Status of Zika Virus in the 50 states and DC
 Local vector-borne transmission of Zika virus has not been reported in the 
continental United States
 With current outbreak in the Americas, cases among U.S. travelers will 
likely increase
 Imported cases may result in virus introduction and local transmission in 
some areas of U.S.
 Zika Action Plan Summit at CDC 4/1/16 to assist states in the development 
of response plans
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Zika Virus in Pregnancy
 Limited information demonstrates:
– No evidence of increased susceptibility
– Infection can occur in any trimester
– Incidence of Zika virus infection in pregnant women is 
not known
– No evidence of more severe disease compared with 
non-pregnant people
Centers for Disease Control and Prevention, CDC Health Advisory:  Recognizing, Managing, and Reporting Zika Virus Infections in Travelers Returning from Central America, South America, the 
Caribbean and Mexico, 2016.
Besnard, M., et al., Evidence of Perinatal Transmission of Zika Virus, French Polynesia, December 2013 and February 2014. Euro Surveill, 2014. 19(14): p. 1-5.
Oliveira Melo, A., et al., Zika Virus Intrauterine Infection Causes Fetal Brain Abnormality and Microcephaly: Tip of the Iceberg? Ultrasound in Obstetrics & Gynecology, 2016. 47(1): p. 6-7.
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Zika Virus – Fetal Brain Abnormalities
 2016 Brazil study: 42 women with laboratory-confirmed Zika virus 
infection with prenatal ultrasound
– 12 (29%) abnormalities detected, including 2 intrauterine fetal deaths
– 7 (17%) structural brain anomalies (microcephaly, calcifications, cerebellar atrophy, 
ventriculomegaly)
 2013-14 outbreak in French Polynesia
– 8 cases of microcephaly identified 
– Modeling estimated infection with Zika during 1st trimester of pregnancy resulted in 
microcephaly risk of ≈1%
Brasil P, Pereira JP Jr, Raja Gabaglia C, et al. Zika virus infection in pregnant women in Rio de Janeiro—preliminary report. N Engl J Med 2016. Published
online March 4, 2016. Link to Brasil et al article
Cauchemez S, Besnard M, Bomopard P, et al. Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study. Lancet 2016. 
Published online March 15, 2016. Link to Cauchemez et al article
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Zika Virus – Fetal Brain Abnormalities and Prolonged Viremia
2016 case report: pregnant woman with symptom onset 12 weeks’ gestation 
 Prenatal ultrasound
– No prenatal diagnosis of microcephaly 
– Decrease in head circumference from 47th to 24th percentile 16-20 weeks
– Abnormal intracranial anatomy at 19 weeks 
– Fetal MRI at 20 weeks: brain abnormalities, including diffuse cerebral atrophy
 Postmortem evaluation
– Diffuse cerebral cortical thinning
– High levels of Zika virus RNA; positive viral culture
Driggers RW, Ho C-Y, Korhonen EM, et al. Zika virus infection with prolonged maternal viremia ad fetal brain abnormalities. NEJM 2016 Mar 30. 
DOI: 10.1056/NEJMoa1601824
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Centers for Disease Control and Prevention
UPDATE: Interim Guidance for Prevention of Sexual 
Transmission of Zika Virus – United States, 2016
Speaker: John T. Brooks, MD
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Centers for Disease Control and Prevention
CDC’s updated pediatric guidance
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Centers for Disease Control and Prevention
Sexual transmission April 1, 2016
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Sexual Transmission of Zika Virus: 
What We Know and What We Do Not Know
What we know:
 Zika virus can be sexually transmitted by a man to his sex partners (female and 
male), and this is of particular concern during pregnancy
‐ All reported cases of sexual transmission involved sex without a condom with men 
who had or developed symptoms
‐ Zika virus can be transmitted when the man has symptoms, before symptoms start, 
and after symptoms end
 Sexual transmission of many infections, including those caused by other 
viruses, is reduced by consistent and correct use of latex condoms
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Sexual Transmission of Zika Virus: 
What We Know and What We Do Not Know
What we do not know:
 Whether infected men who never develop symptoms can transmit Zika virus to 
their sex partners.
 How long Zika virus persists in the semen.
‐ Infectious virus (culture) in semen at least 14 days after symptoms of infection began
‐ Virus particles (RT-PCR) in semen at least 62 days after symptoms of infection began
 Whether women with Zika infection can transmit Zika virus to their sex 
partners
 Whether Zika can be transmitted from oral sex
‐ It is known that Zika is infectious in semen
‐ It is unknown if Zika is infectious in other body fluids exchanged by oral sex, including saliva and 
vaginal fluids
21Sexual Transmission of Zika Virus: CDC Recommendations for Men 
Who Live in or Traveled to an Area of Active Zika Virus Transmission
Couples in which a woman is pregnant 
 Use condoms consistently and correctly or abstain from sex for the duration of the pregnancy 
Other couples concerned about sexual transmission 
 If man had confirmed Zika virus infection or clinical illness consistent with Zika virus disease
– Should consider using condoms or abstaining from sex for at least 6 months after illness onset 
 If man traveled to an area with active Zika virus transmission but did not develop symptoms
– Should consider using condoms or abstaining from sex for at least 8 weeks after departure from 
the area
 If man resides in an area with active Zika virus transmission but has not developed symptoms
– Might consider using condoms or abstaining from sex while active transmission persists 
Oster AM, et al. Interim Guidelines for Prevention of Sexual Transmission of Zika Virus — United States, 2016. MMWR Morb Mortal Wkly Rep 2016;65:323-325
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Sexual Transmission of Zika Virus: CDC Recommendations for Men 
Who Live in or Traveled to an Area of Active Zika Virus Transmission
Testing to determine risk of sexual transmission not recommended
 Tests to detect Zika virus in semen are not widely available 
 We have limited understanding of how to interpret the results of such tests
– Inadequate data on the incidence, persistence, and shedding pattern of Zika in 
semen to make recommendations
Oster AM, et al. Interim Guidelines for Prevention of Sexual Transmission of Zika Virus — United States, 2016. MMWR Morb Mortal Wkly Rep 2016;65:323-325
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Communicating about the Prevention of Sexual Transmission
Talking about the sexual transmission of Zika virus can be complicated
 Anyone concerned about getting Zika virus from sex can use condoms or choose not to have sex
 To be effective, condoms must be used correctly from start to finish, every time during sex
 Sex includes vaginal, anal and oral (mouth-to-penis) sex
 There may be barriers to accessing and using condoms including availability, price, and a 
person’s ability to convince their partner to use condoms
 Couples who do not desire pregnancy should use the most effective contraceptive methods that 
can be used correctly and consistently in addition to condoms (also effective against STDs)*
 Religious beliefs may restrict a person’s ability to use condoms or other contraception
* Discussed in more detail in the following: Petersen EE, Polen KN, Meaney-Delman D, et al. Update: interim guidance for health care 
providers caring for women of reproductive age with possible Zika virus exposure—United States, 2016. MMWR Morb Mortal Wkly
Rep 2016. Published online March 25, 2016.
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Centers for Disease Control and Prevention
Update: Interim Guidance for Health Care Providers 
Caring for Women of Reproductive Age with Possible 
Zika Virus Exposure — United States, 2016
Speaker: Christine K. Olson, MD, MPH, CAPT, USPHS
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CDC Guidance
 Interim Guidelines for Pregnant Women During a Zika Virus Outbreak —
United States, 2016 (January 22, 2016)
 Update: Interim Guidelines for Health Care Providers Caring for Pregnant 
Women and Women of Reproductive Age with Possible Zika Virus 
Exposure — United States, 2016 (February 12, 2016)
 Update: Interim Guidance for Health Care Providers Caring for Women of 
Reproductive Age with Possible Zika Virus Exposure — United States, 2016 
(March 25, 2016)
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Centers for Disease Control and Prevention
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CDC Recommendations: 
Pregnant Women and Women of Reproductive Age With 
Possible Zika Virus Exposure
 Updated guidance includes: 
– Recommendations for women and couples who want to conceive
– Special considerations for women and couples seeking infertility 
treatment and women living along the US-Mexico border
– Minor modifications to the pregnancy guidance/algorithm
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Definitions
 Possible exposure: 
– travel to or residence in an area of active Zika virus transmission 
– sex (vaginal, anal, or oral [penis-to-mouth]) without a condom with a man who 
traveled to or resided in an area of active transmission*
 Zika virus infection: laboratory-confirmation of Zika virus, including asymptomatic 
persons
 Zika virus disease: having at least one of the following signs or symptoms: acute 
onset of fever, rash, arthralgia, conjunctivitis and laboratory-confirmation of Zika 
virus infection 
*http://www.cdc.gov/zika/geo/active-countries.html
29Recommendations for Women and Men Interested in 
Conceiving Who DO NOT Reside In an Area With Active Zika 
Virus Transmission
For Women With Possible Exposure to Zika Virus
– Health care providers (HCPs) should discuss signs and symptoms and 
potential adverse outcomes associated with Zika 
– If Zika virus disease diagnosed, wait at least 8 weeks after symptom 
onset to attempt conception
– If NO symptoms develop, wait at least 8 weeks after last date of 
exposure before attempting conception
30Recommendations for Women and Men Interested in 
Conceiving Who DO NOT Reside In an Area With Active Zika 
Virus Transmission
For Men With Possible Exposure to Zika Virus
– If Zika virus disease diagnosed, wait at least 6 months after symptom onset 
– If NO symptoms develop, wait at least 8 weeks after exposure 
– Discuss contraception and use of condoms
31Recommendations for Women and Men Interested in 
Conceiving Who Reside In an Area With Active Zika Virus 
Transmission
 Women and men interested in conceiving should talk with their HCPs 
 Factors that may aid in decision-making:
• Reproductive life plan
• Environmental risk of exposure
• Personal measures to prevent mosquito bites
• Personal measures to prevent sexual transmission
• Education about Zika virus infection in pregnancy
• Risks and benefits of pregnancy at this time
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Clinical Tool
Link to Preconception Counseling Clinical Tool
33Recommendations for Women and Men Interested in 
Conceiving Who Reside In an Area With Active Zika Virus 
Transmission
- If couples decide to attempt conception:
- Recommended use of EPA-registered insect repellent and safety to use during 
pregnancy 
- Recommendations to wait to attempt conception if one or both members of the 
couple have Zika virus disease:
- For at least 8 weeks for women who have Zika virus disease
- For at least 6 months for men who have Zika virus disease
- Recommendation for correct and consistent use of condoms or abstaining from 
sex for duration of pregnancy
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Recommendations for Women and Men Interested in 
Conceiving Who Reside In an Area With Active Zika Virus 
Transmission
- If couples decide to wait to conceive, HCPs should discuss
- Strategies to prevent unintended pregnancy
- Use of the most effective contraceptive methods that can be used correctly 
and consistently





Special Considerations: Women Undergoing Infertility 
Treatment 
 No known Zika virus transmission during infertility treatment 
 Transmission through donated gametes or embryos theoretically 
possible
 Virus unlikely to be destroyed by cryopreservation
 Couples using own gametes or embryos should follow 
recommendations for men and women attempting conception
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Special Considerations: Women Undergoing Infertility Treatment –
FDA Guidance for Donated Tissues During Zika Outbreak
Living donors ineligible for anonymous donation if: 
• Medical diagnosis of Zika virus infection in the past 6 months
• Resided in or traveled to an area with active Zika virus transmission in 
past 6 months
• Within the past 6 months had sex with a male partner who, during the 6 
months before the sexual contact, was diagnosed with or experienced an 
illness consistent with Zika virus disease or had traveled to an area of 
active Zika virus transmission
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Special Considerations – Pregnant Women Living Along 
the U.S.-Mexico Border
 HCPs should assess patients’ travel histories
– Frequency of cross-border travel and destinations
– Include discussion of sexual partners’ travel
 Local health officials to determine when to implement 
testing of asymptomatic pregnant women based on 







 Reverse transcription-polymerase chain reaction (RT-PCR) for viral RNA in 
serum collected ≤7 days after symptom onset
 Serology for immunoglobulin M (IgM) in serum collected ≥4 days after 
illness onset
 HCPs need to work with their health departments to arrange testing
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CDC Recommendations: 
Testing for Asymptomatic Pregnant Women with Possible 
Zika Virus Exposure
 Serologic (IgM) testing can be offered to asymptomatic pregnant women
 Negative IgM result within 2-12 weeks after exposure could suggest a 
recent infection did not occur and obviate serial ultrasounds
 Information about performance of testing of asymptomatic persons limited
42Updated Recommendations
Testing of PREGNANT Women With Possible Zika Virus 
Exposure Who DO NOT Reside in An Area With Active Zika 
Virus Transmission
 If one or more signs/symptoms of Zika virus disease within 2 weeks of 
travel, serum testing should be performed
 Testing can be offered to asymptomatic pregnant women with possible 
exposure
– History of travel to an area with active Zika virus transmission or 
– Sex without a condom with a symptomatic male
 Testing is not currently recommended for pregnant women with possible 
sexual exposure to Zika virus if both partners are asymptomatic
43Interim Guidelines (3/25/16):
Pregnant Women With Possible Zika Virus Exposure NOT 
Residing in an Area With Active Zika Virus Transmission
44Updated Recommendations: 
Testing for PREGNANT Women Residing in An Area With 
Active Zika Virus Transmission
 If one or more signs/symptoms of Zika virus disease, testing should 
be performed at presentation
 If the woman does not report one or more signs/symptoms of Zika 
virus disease, serum IgM testing for Zika virus can be offered:
– Upon initiation of prenatal care, and (if negative)
– In mid-second trimester
 Repeat testing if develops symptoms
45Interim Guidelines (3/25/16):
Pregnant Women Residing in Areas With Active Zika 
Virus Transmission
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Preventing Transmission of Zika Virus in Labor 




Zika Virus Disease in Labor and Delivery Settings
 Zika virus has been detected in blood, amniotic fluid, 
urine, saliva, and semen
 No reports to date of transmission of Zika virus 
transmission from infected patients to HCP or other 
patients
 Healthcare personnel (HCP) working in these settings 
must adhere to Standard Precautions
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Standard Precautions
 Standard precautions – basic measures to prevent infections that apply to all 
patient care 
– Prevent contact between a patient’s body fluids and HCPs’ mucous membranes, 
skin, and clothing 
– Prevent HCP from transmitting potentially infectious material from one patient to 
another
– Avoid exposure to contaminated sharp implements
 Include: hand hygiene, personal protective equipment (PPE), safe injection 
practices, safe handling of contaminated materials
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Risk Assessment and Choosing Appropriate PPE 
 HCPs must asses their risk for exposure and select appropriate PPE 
– Examples of obstetric procedures that require increasing levels of PPE: 
• Vaginal exam particularly during amniotomy
• Vaginal delivery including manual removal of placenta
• Operative procedures 
 Factors to consider 
– Anticipated exposure to blood and body fluids, including splashes
– Protection of  mucous membranes, particularly the eyes
50
Additional measures
 Placement of disposable absorbent material on floor around 
procedure and delivery area
 Accessibility and availability of PPE and infection control 
supplies during emergencies 
 Standard cleaning and disinfection for environmental surfaces
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Reporting and Ongoing Education and Training 
 Report all occupational exposures to facility’s occupational 
health clinic 
 Provide ongoing education/training about Standard 
Precautions and PPE 
 Address barriers to use of Standard Precautions PPE when 
identified
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Centers for Disease Control and Prevention
Updated Guidelines – Application to Infants
and
U.S. Zika Pregnancy Registry
Speaker: Jefferson M. Jones, MD, MPH, LCDR, USPHS
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Guidelines for Evaluation and Testing of Infants Whose Mothers 
Traveled to or Resided in an Area with Ongoing Transmission During 
Pregnancy
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Guidelines for Evaluation and Testing of Infants Whose Mothers 
Traveled to or Resided in an Area with Ongoing Transmission During 
Pregnancy
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Guidelines for Evaluation and Testing of Infants Whose Mothers 
Traveled to or Resided in an Area with Ongoing Transmission During 
Pregnancy
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U.S. Zika Pregnancy Registry 
 Purpose of registry: To monitor pregnancy and infant 
outcomes following Zika virus infection during pregnancy and 
to inform clinical guidance and public health response
 How it works: The registry is a supplemental surveillance 
effort coordinated by CDC and dependent on the voluntary 
collaboration of the state, tribal, local, and territorial health 
departments
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U.S. Zika Pregnancy Registry 
 Who is included: Pregnant women with laboratory evidence 
of Zika virus infection and exposed infants born to these 
women; infants with laboratory evidence of congenital Zika 
virus infection and their mothers
 How can you support the registry? Spread the word about 
the US Zika Pregnancy Registry and assist with health 
department follow-up for pregnant women and infants 
who are part of the registry
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More information about Zika
 More information is available on the U.S. Zika Pregnancy Registry website 
at Registry website To contact CDC Registry staff, call the CDC Emergency 
Operations Center watch desk at 770-488-7100 and ask for the Zika 
Pregnancy Hotline or email ZIKApregnancy@cdc.gov
 More information on caring for pregnant women, infants, or children with 
Zika virus infection is available at CDC's Zika website. 
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For more information, contact CDC
1-800-CDC-INFO (232-4636)
TTY:  1-888-232-6348    www.cdc.gov
The findings and conclusions in this report are those of the authors and do not necessarily represent the 
official position of the Centers for Disease Control and Prevention.
Thanks to our many collaborators and partners!
For clinical questions, please contact
ZikaMCH@cdc.gov
For U.S. Zika Pregnancy Registry questions, please contact
ZikaPregnancy@cdc.gov
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Centers for Disease Control and Prevention
Updated Guidelines – Application to Infants
and
U.S. Zika Pregnancy Registry




Testing for Persons with Possible Zika Virus Exposure 
Who Are Attempting Conception 
 Testing of serum should be performed in persons with possible exposure to 
Zika virus who have one or more Zika-related symptoms
 Routine testing is not currently recommended for women or men who are 
attempting conception who have possible exposure to Zika virus but have 
NO symptoms
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Updated CDC Recommendations:  
Women and Men Interested in Conceiving
Background: viremia
– No current evidence that Zika virus will cause congenital infection in 
pregnancies conceived after resolution of maternal Zika viremia
– Incubation period for Zika virus disease 3-14 days
– Viremia range from a few days to 1 week (longest documented 11 
days)
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Interpretation of Prenatal and Postnatal Findings
 If postnatal findings differ from prenatal, clinical judgment is needed
 Example: Newborn with
1) A prenatal diagnosis of microcephaly 
2) A normal head circumference after birth and normal examination
– Newborn likely considered to NOT have abnormality consistent with 
congenital Zika virus disease 
– Newborn would qualify for right side of algorithm
– Newborn’s testing dependent on mother’s testing
To Ask a Question
 Using the Webinar System
 “Click” the Q&A tab at the top left of the webinar tool bar
 “Click”  in the white space
 “Type” your question
 “Click” ask
 On the Phone
 Press Star (*) 1 to enter the queue
 State your name
 Listen for the operator to call your name 
 State your organization and then ask your question
Thank you for joining!
Please email us questions at coca@cdc.gov
Centers for Disease Control and Prevention 
Atlanta, Georgia
http://emergency.cdc.gov/coca 
Continuing Education  for COCA Calls
Continuing Education guidelines require that the attendance of all who 
participate in COCA Conference Calls be properly documented. All 
Continuing Education credits/contact hours (CME, CNE, CEU, CECH, ACPE 
and AAVSB/RACE) for COCA Conference Calls/Webinars are issued online 
through the CDC Training & Continuing Education Online system 
(http://www.cdc.gov/TCEOnline/).
Those who participate in the COCA Conference Calls and who wish to 
receive CE credit/contact hours and will complete the online evaluation by 
May 12, 2016 will use the course code WC2286. Those who wish to receive 
CE credits/contact hours and will complete the online evaluation between 
May 13 , 2016 and April 11, 2017 will use course code WD2286. CE 
certificates can be printed immediately upon completion of your online 
evaluation. A cumulative transcript of all CDC/ATSDR CE’s obtained through 
the CDC Training & Continuing Education Online System will be maintained 
for each user. 
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